NCT05778851 2025-10-30
ASBE
Lucid Diagnostics, Inc.
Phase NA Completed
Clinical Trials
10 trialsNCT02597712 2021-04-12
YF476 in Barrett's Esophagus
Trio Medicines Ltd.
Phase 2 Completed
NCT02395471 2019-07-30
CASEII
Medtronic - MITG
Phase NA Completed
NCT00282672 2017-11-06
Ablation of Intestinal Metaplasia Containing Dysplasia
Medtronic - MITG
Phase NA Completed
NCT02162758 2017-05-11
Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency Ablation
Takeda
Phase 2 Terminated
NCT00489268 2017-03-13
AIM
Medtronic - MITG
Phase NA Completed
NCT00795184 2016-05-03
DONTBIOPCE
Mauna Kea Technologies
Phase NA Completed
NCT01032044 2016-04-22
CLEAN-MARGIN
Mauna Kea Technologies
Phase NA Completed
NCT00848237 2016-02-05
HALO Patient Registry: Ablation of Barrett's Esophagus
Medtronic - MITG
Phase NA Completed
NCT00754468 2015-11-04
ESODOI
CSA Medical, Inc.
Phase 4 Completed